1834 Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

1834 Investment Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-233	Closed	-$7K	–	211
2022 Q2	$7K	Hold	233	–	–	﹤0.01%	392
2022 Q1	$11K	Hold	233	–	–	﹤0.01%	345
2021 Q4	$14K	Hold	233	–	–	﹤0.01%	356
2021 Q3	$17K	Hold	233	–	–	﹤0.01%	353
2021 Q2	$22K	Hold	233	–	–	﹤0.01%	352
2021 Q1	$21K	Hold	233	–	–	﹤0.01%	318
2020 Q4	$22K	Hold	233	–	–	﹤0.01%	310
2020 Q3	$15K	Buy	+233	New	+$13.7K	﹤0.01%	322

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

1834 Investment Advisors's ARKG Position: Q3 2022 in Review

1834 Investment Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 233 shares — an estimated $7K sold.

1834 Investment Advisors first reported a position in ARKG in Q3 2020 and held it in 8 quarters. The position peaked at $22K in Q2 2021. 312 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

1834 Investment Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
1834 Investment Advisors sold 233 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $7K.
1834 Investment Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 8 quarters.
1834 Investment Advisors's ARK Genomic Revolution ETF position peaked at $22K in Q2 2021.
312 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.